1. Childers WE, Abou-Gharbia MAJAMCL (2021) “I’ll be back”: the resurrection of dezocine. ACS Med Chem Lett 12(6):961–968
2. Xue C, Chen W, Yuan A, Chen C, Li S, Chen K, Zhao Y, Xiao T, Shao G, Zou YJFIP (2021) Dezocine, an opioid analgesic, exerts antitumor effects in triple-negative breast cancer by targeting nicotinamide phosphoribosyltransferase. Front Pharmacol 12:600296
3. Hu X, Luo B, Qiu L, Chen S, Wu Q, Chen Q, Liu X, Ling C, Deng S, Yuan M, Hu P (2022) Dezocine Has the Potential to Regulate the Clinical and Biological Features of Tumors. Drug Des Dev Ther 16:1121–1129
4. Investigation Report on China's Dezocine Market, 2021–2025 (2021) China Research & Intelligence, China. https://www.researchandmarkets.com/reports/5312018/investigation-report-on-chinas-dezocine-market. Accessed Apr 2023
5. Dezocine Market Size, Share, Growth Statistics, Leading Players and Forecast 2028 (2023) https://www.marketwatch.com/press-release/dezocine-market-size-share-growth-statistics-leading-players-and-forecast-2028-2023-02-08. Accessed 30 May 2023